PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus
Go back to PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 65.37 -2.63 (3.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.00 | 52 Week High | $35.40 | |||
| Open | $68.00 | 52 Week Low | $4.03 | |||
| Day High | $68.01 | P/E | 6.95 | |||
| Day Low | $65.18 | EPS | $9.40 | |||
| Volume | 3,678,330 | |||||
